Nine Chapters Capital Management’s Integra LifeSciences IART Stock Holding History

Nine Chapters Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-39,388	Closed	-$1.08M	–	1084
2015 Q2	$1.08M	Buy	+39,388	New	+$1.05M	0.09%	316
2014 Q1	–	Sell	-18,593	Closed	-$363K	–	884
2013 Q4	$363K	Buy	+18,593	New	+$341K	0.04%	566

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nine Chapters Capital Management's IART Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of Integra LifeSciences (IART) in Q3 2015, closing a stake of 39,388 shares — an estimated $1.08M sold.

Nine Chapters Capital Management first reported a position in IART in Q4 2013 and held it in 2 quarters. The position peaked at $1.08M in Q2 2015. 189 funds tracked by Wall St. Rank hold IART as of Q3 2015.

Nine Chapters Capital Management reported no remaining Integra LifeSciences position as of Q3 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 39,388 Integra LifeSciences shares in Q3 2015, an estimated $1.08M.
Nine Chapters Capital Management first reported a position in Integra LifeSciences in Q4 2013 and held it in 2 quarters.
Nine Chapters Capital Management's Integra LifeSciences position peaked at $1.08M in Q2 2015.
189 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.